Search | TVST | ARVO Journals

Showing 1 – 20 of 25

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Efficacy of intravitreal pegcetacoplan in patients with geographic atrophy (GA): 12-month results from the phase 3 OAKS and DERBY studies.

Roger Goldberg; Jeffrey S Heier; Charles Clifton Wykoff; Giovanni Staurenghi; Rishi P Singh; Nathan Steinle; David S Boyer; Jordi Mones; Frank G Holz; Caleb Bliss; Federico Grossi; Ravi Metlapally; Ramiro Ribeiro

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1500.

ARVO Annual Meeting Abstract June 2022

Safety and Efficacy of a Phase 1/2a Clinical Trial of Transplanted Allogeneic Retinal Pigmented Epithelium (RPE, OpRegen) Cells in Advanced Dry Age-Related Macular Degeneration (AMD)

Allen C Ho; Eyal Banin; Adiel Barak; David S Boyer; Rita Ehrlich; Tareq Jaouni; H Richard MacDonald; Christopher D Riemann; David Telander; Jordi Mones; Avi Ben Shabat; Gary S Hogge; Benjamin Reubinoff

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1862.

ARVO Annual Meeting Abstract June 2021

Phase I/IIa Clinical Trial of Transplanted Allogeneic Retinal Pigmented Epithelium (RPE, OpRegen) Cells in Advanced Dry Age-Related Macular Degeneration (AMD): Interim Results

Christopher D Riemann; Eyal Banin; Adiel Barak; David S Boyer; Rita Ehrlich; Allen Ho; Tareq Jaouni; Richard McDonald; David Telander; Jordi Mones; Joyce Velez; Gary S. Hogge; Benjamin Reubinoff

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3316.

ARVO Annual Meeting Abstract June 2020

Phase I/IIa Clinical Trial of Human Embryonic Stem Cell (hESC)-Derived Retinal Pigmented Epithelium (RPE, OpRegen) Transplantation in Advanced Dry Form Age-Related Macular Degeneration (AMD): Interim Results

Christopher D Riemann; Eyal Banin; Adiel Barak; David S Boyer; Rita Ehrlich; Tareq Jaouni; Richard McDonald; David Telander; Michael Keane; Jessica Ackert; Mark D. Ferguson; Avi Ben- Shabat; Jordi Mones; Diana Angelini; Gary S. Hogge; Benjamin Reubinoff

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):865.

ARVO Annual Meeting Abstract June 2020

Genotype-phenotype correlation in geographic atrophy secondary to age-related macular degeneration. The EYE-RISK Consortium

Marc Biarnes Perez; Johanna Colijn; Jose Sousa; Lucia Ferraro; Míriam Garcia; Timo Verzijden; Magda A. Meester; Cecile Delcourt; Caroline Klaver; Anneke Den Hollander; Imre Lengyel; Tunde Peto; Jordi Monés

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3520.

ARVO Annual Meeting Abstract June 2020

Transplantation of human induced pluripotent stem cells (hiPSC)-derived retinal pigment epithelium (RPE) cell suspension into the subretinal space of a swine model of geographic atrophy (GA).

LUCIA LEE FERRARO; Anna Duarri; Eduardo Rodríguez-Bocanegra; gema martínez; Marc Biarnes Perez; Míriam Garcia; Bernd Kuebler; Begoña Aran Corbella; Elisabeth Izquierdo; Eli Aguilera xiol; Ricardo Pedro Casaroli-Marano; Esteve Trias; Eduardo Fernandez; Ángel Raya; Anna Veiga; Jordi Mones

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):864.

ARVO Annual Meeting Abstract July 2019

Bleb resolution time following subretinal injections of a cell therapy in porcine eyes appears sensitive to formulation osmolarity

Jordi Mones; Rick Beckman; Kieran O'donovan; Ryan Woodward; Marc Biarnés; Eduardo Rodriguez; Miriam Garcia; Lucia Ferraro; Eli Aguilera; Elisabet Izquierdo; Blanca Reyes; Sara Patel

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6398.

ARVO Annual Meeting Abstract July 2019

Development of a Genotyping Assay for Age-Related Macular Degeneration: The EYE-RISK Consortium

Anita de Breuk; Ilhan Erkin Acar; Magda Meester; Mascha MVAP Schijvenaars; Eveline Kersten; Jordi Mones; Daniel Pauleikhoff; Rufino Silva; Sascha Fauser; Carel C B Hoyng; Cecile DelCourt; Caroline C W Klaver; Marieke JH Coenen; Anneke I Den Hollander

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2955.

Articles December 2018

The Rate of Progression of Geographic Atrophy Decreases With Increasing Baseline Lesion Size Even After the Square Root Transformation

PDF

Jordi Monés; Marc Biarnés
TAGS: atrophy
Trans. Vis. Sci. Tech.. 2018; 7(6):40. https://doi.org/10.1167/tvst.7.6.40

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

Natural history of geographic atrophy secondary to age-related macular degeneration: Proxima A data from the 1-year analysis of 100 patients

Giovanni Staurenghi; Nancy Holekamp; Jordi Mones; Fan Tang; Barbara Tong; Ronald A Cantrell; Christopher Brittain; Jason Ehrlich; Hugh Lin; Charles Clifton Wykoff

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5545.

ARVO Annual Meeting Abstract June 2017

Results of intravitreal aflibercept in patients with neovascular age-related macular degeneration, without optimal response to anti VEGF-A therapy. MACBETH STUDY

Marc Biarnes Perez; Jordi Monés

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):878.

ARVO Annual Meeting Abstract June 2017

Understanding the natural history of geographic atrophy secondary to age-related macular degeneration: Baseline data from Proxima A

Brandon Busbee; Jordi Monés; Charles Clifton Wykoff; Giovanni Staurenghi; Fan Tang; Barbara Tong; Ronald A Cantrell; Christopher Brittain; Jason Ehrlich; Hugh Lin; Nancy Holekamp

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1511.

ARVO Annual Meeting Abstract June 2017

Validation of an adaptive optics scanning laser ophthalmoscope prototype in patients with degenerative retinal diseases.The LITE study.

LUCIA LEE FERRARO; david merino; Marc Biarnes Perez; Miriam Garcia Planas; Anna Borrell; Pablo Loza; Jordi Monés

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):309.

ARVO Annual Meeting Abstract September 2016

Identification of subgroups in geographic atrophy using cluster analysis

Marc Biarnes; Jordi Mones

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):53.

ARVO Annual Meeting Abstract September 2016

Dark adaptation impairment in patients with drusen

Miriam Garcia Planas; Marc Biarnes; Jordi Mones

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3706.

ARVO Annual Meeting Abstract September 2016

Efficacy of ranibizumab treatment in retinal vein occlusion patients with retinal macular ischemia: 24-month data from BRIGHTER and CRYSTAL

Jordi Mones

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5157.

Retina August 2016

A Swine Model of Selective Geographic Atrophy of Outer Retinal Layers Mimicking Atrophic AMD: A Phase I Escalating Dose of Subretinal Sodium Iodate

PDF

Jordi Monés; Marta Leiva; Teresa Peña; Gema Martínez; Marc Biarnés; Miriam Garcia; Anna Serrano; Eduardo Fernandez
TAGS: atrophic condition of skin, atrophy, iodates, sodium, suidae, follow-up
Invest. Ophthalmol. Vis. Sci.. 2016; 57(10):3974-3983. https://doi.org/10.1167/iovs.16-19355

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2015

Evaluation of ranibizumab for macular ischemia in retinal vein occlusion: evidence from the BRIGHTER and CRYSTAL studies

Jordi Mones; Brighter and Crystal

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5803.

Clinical and Epidemiologic Research December 2014

Reappraisal of Geographic Atrophy Patterns Seen on Fundus Autofluorescence Using a Latent Class Analysis Approach

PDF

Marc Biarnés; Carlos G. Forero; Luis Arias; Jordi Alonso; Jordi Monés
TAGS: atrophy, fundus autofluorescence imaging
Invest. Ophthalmol. Vis. Sci.. 2014; 55(12):8302-8308. https://doi.org/10.1167/iovs.13-13542

Includes: Supplemental Content

ARVO Annual Meeting Abstract April 2014

Efficacy and safety of ranibizumab 0.5 mg in patients with visual impairment due to macular edema secondary to central retinal vein occlusion: Design and baseline characteristics of the CRYSTAL study

Francesco Boscia; Heinrich Gerding; Ian A Pearce; Siegfried Priglinger; Ramin Tadayoni; Jackie Han; George Lambrou; William John Stubbings; Jordi M Mones

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):606.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Efficacy of intravitreal pegcetacoplan in patients with geographic atrophy (GA): 12-month results from the phase 3 OAKS and DERBY studies.

Safety and Efficacy of a Phase 1/2a Clinical Trial of Transplanted Allogeneic Retinal Pigmented Epithelium (RPE, OpRegen) Cells in Advanced Dry Age-Related Macular Degeneration (AMD)

Phase I/IIa Clinical Trial of Transplanted Allogeneic Retinal Pigmented Epithelium (RPE, OpRegen) Cells in Advanced Dry Age-Related Macular Degeneration (AMD): Interim Results

Phase I/IIa Clinical Trial of Human Embryonic Stem Cell (hESC)-Derived Retinal Pigmented Epithelium (RPE, OpRegen) Transplantation in Advanced Dry Form Age-Related Macular Degeneration (AMD): Interim Results

Genotype-phenotype correlation in geographic atrophy secondary to age-related macular degeneration. The EYE-RISK Consortium

Transplantation of human induced pluripotent stem cells (hiPSC)-derived retinal pigment epithelium (RPE) cell suspension into the subretinal space of a swine model of geographic atrophy (GA).

Bleb resolution time following subretinal injections of a cell therapy in porcine eyes appears sensitive to formulation osmolarity

Development of a Genotyping Assay for Age-Related Macular Degeneration: The EYE-RISK Consortium

The Rate of Progression of Geographic Atrophy Decreases With Increasing Baseline Lesion Size Even After the Square Root Transformation

Natural history of geographic atrophy secondary to age-related macular degeneration: Proxima A data from the 1-year analysis of 100 patients

Results of intravitreal aflibercept in patients with neovascular age-related macular degeneration, without optimal response to anti VEGF-A therapy. MACBETH STUDY

Understanding the natural history of geographic atrophy secondary to age-related macular degeneration: Baseline data from Proxima A

Validation of an adaptive optics scanning laser ophthalmoscope prototype in patients with degenerative retinal diseases.The LITE study.

Identification of subgroups in geographic atrophy using cluster analysis

Dark adaptation impairment in patients with drusen

Efficacy of ranibizumab treatment in retinal vein occlusion patients with retinal macular ischemia: 24-month data from BRIGHTER and CRYSTAL

A Swine Model of Selective Geographic Atrophy of Outer Retinal Layers Mimicking Atrophic AMD: A Phase I Escalating Dose of Subretinal Sodium Iodate

Evaluation of ranibizumab for macular ischemia in retinal vein occlusion: evidence from the BRIGHTER and CRYSTAL studies

Reappraisal of Geographic Atrophy Patterns Seen on Fundus Autofluorescence Using a Latent Class Analysis Approach

Efficacy and safety of ranibizumab 0.5 mg in patients with visual impairment due to macular edema secondary to central retinal vein occlusion: Design and baseline characteristics of the CRYSTAL study

To View More...

You must be signed into an individual account to use this feature.